lysophosphatidic acid has been researched along with Malignant Melanoma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Ishimoto, K; Minami, K; Tsujiuchi, T; Ueda, N | 1 |
| Insall, RH; Kamphorst, JJ; Koh, YWH; Mackay, GM; Morrice, N; Muinonen-Martin, AJ; Nielson, M; Susanto, O; Thomason, PA; Tumanov, S; Tweedy, L | 1 |
| Hegedüs, B; Rásó, E; Tímár, J | 1 |
| Ishimoto, K; Maeda, H; Minami, K; Otagaki, S; Tsujiuchi, T; Ueda, N | 1 |
| Al-Shami, A; Fujiwara, Y; Oda, SK; Oravecz, T; Pelanda, R; Strauch, P; Tigyi, G; Torres, RM | 1 |
| Bennett, DC; Faller, WJ; Herd, R; Insall, RH; Jones, R; Kalna, G; Knecht, DA; Lindsay, C; Machesky, LM; Muinonen-Martin, AJ; Sansom, OJ; Smethurst, E; Susanto, O; Veltman, DM; Wakelam, MJ; Zhang, Q | 1 |
| Argenzio, E; Boumeester, AJ; Innocenti, M; Jalink, K; Kedziora, KM; Leyton-Puig, D; Moolenaar, WH; van Butselaar, B; van Leeuwen, FN; Wu, YI; Yin, T | 1 |
| Hövelmann, F; Jalink, K; Kedziora, KM; Müller, R; Nadler, A; Schultz, C | 1 |
| Chen, XP; Kang, TS; Ko, CN; Leung, CH; Liang, JX; Lu, JJ; Ma, DL; Wang, W; Zhong, HJ | 1 |
| Brindley, DN; Gaetano, C; Goping, IS; Samadi, N | 1 |
| Brindley, DN; Gaetano, CG; Lynch, KR; Macdonald, TL; Samadi, N; Tomsig, JL | 1 |
| Barz, D; Berod, L; Idzko, M; Kamradt, T; Lagadari, M; Lehmann, K; Maghazachi, AA; Norgauer, J; Truta-Feles, K; Ziemer, M | 1 |
| Berliner, C; Bialecki, W; Kleuser, B; Leptin, J; Milićević, NM; Müller, R; Pörtner, D; Schumacher, U | 1 |
| Bar-Eli, M; Calderone, TL; Davies, MA; Gershenwald, JE; Mills, GB; Mu, H; Prieto, VG; Wang, H | 1 |
| Baker, DL; Bandle, RW; Bittman, R; Byun, HS; Fan, D; Fujiwara, Y; Kobayashi, S; Koh, E; Mills, GB; Murakami-Murofushi, K; Murofushi, H; Murph, M; Pigg, KR; Tigyi, G; Tsukahara, R; Uchiyama, A | 1 |
| Baker, DL; Banerjee, S; Lee, SC; Miller, DD; Norman, DD; Parrill, AL; Pham, TC; Tigyi, GJ | 1 |
1 review(s) available for lysophosphatidic acid and Malignant Melanoma
| Article | Year |
|---|---|
The role of lipid signaling in the progression of malignant melanoma.
Topics: Animals; Arachidonic Acid; Cyclooxygenase 2; Disease Progression; Endocannabinoids; Genetic Predisposition to Disease; Humans; Lipid Metabolism; Lysophospholipids; Melanoma; Metabolic Networks and Pathways; Phosphatidylinositol 3-Kinases; Phospholipases; Phosphoric Diester Hydrolases; Prenylation; Prostaglandins; Receptors, Lysophosphatidic Acid; Signal Transduction | 2018 |
15 other study(ies) available for lysophosphatidic acid and Malignant Melanoma
| Article | Year |
|---|---|
Lysophosphatidic acid receptor-2 (LPA
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Humans; Lysophospholipids; Melanoma; Pertussis Toxin; Receptors, Lysophosphatidic Acid; Signal Transduction | 2020 |
LPP3 mediates self-generation of chemotactic LPA gradients by melanoma cells.
Topics: Cell Line, Tumor; Chemotaxis; Humans; Lysophospholipids; Melanoma; Neoplasm Invasiveness; Phosphatidate Phosphatase; Skin Neoplasms | 2017 |
Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lysophospholipids; Melanoma; Receptors, Lysophosphatidic Acid; Signal Transduction | 2019 |
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
Topics: Animals; Carcinogenesis; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Immunologic Surveillance; Lymphocyte Activation; Lysophospholipids; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplastic Processes; Receptors, Lysophosphatidic Acid; Signal Transduction | 2013 |
Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal.
Topics: Animals; Cell Movement; Chemotaxis; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Melanoma; Mice; Neoplasm Metastasis | 2014 |
Rapid Remodeling of Invadosomes by Gi-coupled Receptors: DISSECTING THE ROLE OF Rho GTPases.
Topics: Biomarkers; cdc42 GTP-Binding Protein; Cell Line, Tumor; Endothelins; Extracellular Matrix; Fluorescence Resonance Energy Transfer; Humans; Hydrolysis; Luminescent Proteins; Lysophospholipids; Melanoma; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasm Proteins; Podosomes; rac1 GTP-Binding Protein; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Recombinant Proteins; rhoA GTP-Binding Protein; RNA Interference; Time-Lapse Imaging | 2016 |
Optotaxis: Caged Lysophosphatidic Acid Enables Optical Control of a Chemotactic Gradient.
Topics: Animals; Calcium; Cell Line, Tumor; Cell Movement; Chemotaxis; HeLa Cells; Humans; Lasers; Lysophospholipids; Melanoma; Mice | 2016 |
A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Lysophospholipids; Melanoma; Multienzyme Complexes; NF-kappa B; Phosphodiesterase I; Phosphoric Diester Hydrolases; Rhodium; Signal Transduction; STAT3 Transcription Factor; Structure-Activity Relationship | 2017 |
Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Ceramides; Humans; Lysophosphatidylcholines; Lysophospholipids; Melanoma; Membrane Potential, Mitochondrial; Multienzyme Complexes; Paclitaxel; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |
Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells.
Topics: Anilides; Blotting, Western; Breast Neoplasms; Catalysis; Cell Line; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors; Humans; Kinetics; Lysophosphatidylcholines; Lysophospholipids; Melanoma; Multienzyme Complexes; Organophosphates; Organophosphonates; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyridines; Pyrophosphatases; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Transfection | 2009 |
Lysophosphatidic acid inhibits the cytotoxic activity of NK cells: involvement of Gs protein-mediated signaling.
Topics: Burkitt Lymphoma; Cell Line, Tumor; Class Ia Phosphatidylinositol 3-Kinase; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Humans; Immunologic Surveillance; Killer Cells, Natural; Lysophospholipids; Melanoma; p38 Mitogen-Activated Protein Kinases; Perforin; Phosphatidylinositol 3-Kinases; Receptors, Lysophosphatidic Acid; Signal Transduction; Tumor Escape | 2009 |
Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells.
Topics: Animals; Breast Neoplasms; Colonic Neoplasms; Endothelium, Vascular; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lysophospholipids; Melanoma; Mice; Mice, SCID; Neoplasm Transplantation; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sphingosine; Transplantation, Heterologous; Tumor Cells, Cultured; Umbilical Cord | 2010 |
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
Topics: Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Interleukin-8; Lymphangiogenesis; Lymphatic Metastasis; Lymphatic Vessels; Lysophospholipids; Melanoma; NF-kappa B; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Sentinel Lymph Node Biopsy; Signal Transduction; Up-Regulation | 2012 |
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.
Topics: Antineoplastic Agents; Cell Line, Tumor; Culture Media, Conditioned; Humans; Lipid Metabolism; Lysophospholipids; Melanoma; Multienzyme Complexes; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphatidic Acids; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Recombinant Proteins; Spectrometry, Fluorescence | 2006 |
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.
Topics: Animals; Antineoplastic Agents; Benzenesulfonamides; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Lung; Lung Neoplasms; Melanoma; Mice; Models, Molecular; Neoplasm Invasiveness; Neoplastic Stem Cells; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship; Sulfonamides | 2017 |